Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2023 (unaudited) Expected cash runway, including proceeds from recent private placement, into 2H 2027… Read More
Dr. Jeffrey Smith named Executive Vice President and Chief Medical Officer Dr. John Fann promoted to Senior VP, Process Sciences Seven new Vice Presidents appointed, underscoring commitment to leadership development VANCOUVER, BC – Zymeworks… Read More
Pioneering research traces the branching path of de novo metastatic prostate cancer, uncovering new management paradigms. The sudden onset and severity of de novo metastatic prostate cancer makes it one of the… Read More
Health Canada’s approval of ABRYSVO helps to address the urgent need to minimize the spread of RSV infections – a disease with flu-like symptoms that can result in respiratory distress1,2,3,… Read More
OTTAWA, ON – BioTalent Canada announced a new wage subsidy program that will accelerate the adoption of digital skills by small- and medium-sized businesses in Canada’s biosciences sector, better positioning… Read More
